Sacks & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$279K Hold
1,054
– – 0.19% 70
2026
Q2
$270K Hold
1,054
– – 0.18% 72
2026
Q1
$258K Sell
1,054
-105
-9% -$24.5K 0.19% 71
2025
Q4
$240K Buy
+1,159
New +$229K 0.18% 72

Other funds holding JNJ

Sacks & Associates's JNJ Position: Q3 2026 in Review

Sacks & Associates held its Johnson & Johnson (JNJ) position steady in Q3 2026 at 1,054 shares worth $279K. The position accounts for 0.19% of the portfolio, ranked #70.

Sacks & Associates first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 4,738 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Sacks & Associates held 1,054 shares of Johnson & Johnson worth $279K as of Q3 2026.
  • Sacks & Associates left its Johnson & Johnson share count unchanged in Q3 2026.
  • Johnson & Johnson made up 0.19% of Sacks & Associates's portfolio in Q3 2026, its #70 holding.
  • Sacks & Associates first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • 4,738 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Sacks & Associates's 13F filing for Q3 2026, filed 9 Oct 2026.